Cargando…

Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study

OBJECTIVES: This study sought to investigate the clinical utility and the predictive relevance of absolute rest myocardial blood flow (MBF) by cardiac magnetic resonance (CMR) in acute myocardial infarction. BACKGROUND: Microvascular obstruction (MVO) remains one of the worst prognostic factors in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Borlotti, Alessandra, Jerosch-Herold, Michael, Liu, Dan, Viliani, Dafne, Bracco, Alessia, Alkhalil, Mohammad, De Maria, Giovanni Luigi, Channon, Keith M., Banning, Adrian P., Choudhury, Robin P., Neubauer, Stefan, Kharbanda, Rajesh K., Dall’Armellina, Erica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718360/
https://www.ncbi.nlm.nih.gov/pubmed/30660541
http://dx.doi.org/10.1016/j.jcmg.2018.10.028
_version_ 1783447708963438592
author Borlotti, Alessandra
Jerosch-Herold, Michael
Liu, Dan
Viliani, Dafne
Bracco, Alessia
Alkhalil, Mohammad
De Maria, Giovanni Luigi
Channon, Keith M.
Banning, Adrian P.
Choudhury, Robin P.
Neubauer, Stefan
Kharbanda, Rajesh K.
Dall’Armellina, Erica
author_facet Borlotti, Alessandra
Jerosch-Herold, Michael
Liu, Dan
Viliani, Dafne
Bracco, Alessia
Alkhalil, Mohammad
De Maria, Giovanni Luigi
Channon, Keith M.
Banning, Adrian P.
Choudhury, Robin P.
Neubauer, Stefan
Kharbanda, Rajesh K.
Dall’Armellina, Erica
author_sort Borlotti, Alessandra
collection PubMed
description OBJECTIVES: This study sought to investigate the clinical utility and the predictive relevance of absolute rest myocardial blood flow (MBF) by cardiac magnetic resonance (CMR) in acute myocardial infarction. BACKGROUND: Microvascular obstruction (MVO) remains one of the worst prognostic factors in patients with reperfused ST-segment elevation myocardial infarction (STEMI). Clinical trials have focused on cardioprotective strategies to maintain microvascular functionality, but there is a need for a noninvasive test to determine their efficacy. METHODS: A total of 64 STEMI patients post–primary percutaneous coronary intervention underwent 3-T CMR scans acutely and at 6 months (6M). The protocol included cine function, T(2)-weighted edema imaging, pre-contrast T1 mapping, rest first-pass perfusion, and late gadolinium enhancement imaging. Segmental MBF, corrected for rate pressure product (MBF(cor)), was quantified in remote, edematous, and infarcted myocardium. RESULTS: Acute MBF(cor) was significantly reduced in infarcted myocardium compared with remote MBF (MBF(infarct) 0.76 ± 0.20 ml/min/g vs. MBF(remote) 1.02 ± 0.21 ml/min/g, p < 0.001), but it significantly increased at 6M (MBF(infarct) 0.76 ± 0.20 ml/min/g acute vs. 0.85 ± 0.22 ml/min/g at 6M, p < 0.001). On a segmental basis, acute MBF(cor) had incremental prognostic value for infarct size at 6M (odds of no LGE at 6M increased by 1.4:1 [p < 0.001] for each 0.1 ml/min/g increase of acute MBF(cor)) and functional recovery (odds of wall thickening >45% at 6M increased by 1.38:1 [p < 0.001] for each 0.1 ml/min/g increase of acute MBF(cor)). In subjects with coronary flow reserve >2 or index of myocardial resistance <40, acute MBF was associated with long-term functional recovery and was an independent predictor of infarct size reduction. CONCLUSIONS: Acute MBF by CMR could represent a novel quantitative imaging biomarker of microvascular reversibility, and it could be used to identify patients who may benefit from more intensive or novel therapies.
format Online
Article
Text
id pubmed-6718360
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-67183602019-09-06 Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study Borlotti, Alessandra Jerosch-Herold, Michael Liu, Dan Viliani, Dafne Bracco, Alessia Alkhalil, Mohammad De Maria, Giovanni Luigi Channon, Keith M. Banning, Adrian P. Choudhury, Robin P. Neubauer, Stefan Kharbanda, Rajesh K. Dall’Armellina, Erica JACC Cardiovasc Imaging Article OBJECTIVES: This study sought to investigate the clinical utility and the predictive relevance of absolute rest myocardial blood flow (MBF) by cardiac magnetic resonance (CMR) in acute myocardial infarction. BACKGROUND: Microvascular obstruction (MVO) remains one of the worst prognostic factors in patients with reperfused ST-segment elevation myocardial infarction (STEMI). Clinical trials have focused on cardioprotective strategies to maintain microvascular functionality, but there is a need for a noninvasive test to determine their efficacy. METHODS: A total of 64 STEMI patients post–primary percutaneous coronary intervention underwent 3-T CMR scans acutely and at 6 months (6M). The protocol included cine function, T(2)-weighted edema imaging, pre-contrast T1 mapping, rest first-pass perfusion, and late gadolinium enhancement imaging. Segmental MBF, corrected for rate pressure product (MBF(cor)), was quantified in remote, edematous, and infarcted myocardium. RESULTS: Acute MBF(cor) was significantly reduced in infarcted myocardium compared with remote MBF (MBF(infarct) 0.76 ± 0.20 ml/min/g vs. MBF(remote) 1.02 ± 0.21 ml/min/g, p < 0.001), but it significantly increased at 6M (MBF(infarct) 0.76 ± 0.20 ml/min/g acute vs. 0.85 ± 0.22 ml/min/g at 6M, p < 0.001). On a segmental basis, acute MBF(cor) had incremental prognostic value for infarct size at 6M (odds of no LGE at 6M increased by 1.4:1 [p < 0.001] for each 0.1 ml/min/g increase of acute MBF(cor)) and functional recovery (odds of wall thickening >45% at 6M increased by 1.38:1 [p < 0.001] for each 0.1 ml/min/g increase of acute MBF(cor)). In subjects with coronary flow reserve >2 or index of myocardial resistance <40, acute MBF was associated with long-term functional recovery and was an independent predictor of infarct size reduction. CONCLUSIONS: Acute MBF by CMR could represent a novel quantitative imaging biomarker of microvascular reversibility, and it could be used to identify patients who may benefit from more intensive or novel therapies. Elsevier 2019-09 /pmc/articles/PMC6718360/ /pubmed/30660541 http://dx.doi.org/10.1016/j.jcmg.2018.10.028 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Borlotti, Alessandra
Jerosch-Herold, Michael
Liu, Dan
Viliani, Dafne
Bracco, Alessia
Alkhalil, Mohammad
De Maria, Giovanni Luigi
Channon, Keith M.
Banning, Adrian P.
Choudhury, Robin P.
Neubauer, Stefan
Kharbanda, Rajesh K.
Dall’Armellina, Erica
Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study
title Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study
title_full Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study
title_fullStr Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study
title_full_unstemmed Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study
title_short Acute Microvascular Impairment Post-Reperfused STEMI Is Reversible and Has Additional Clinical Predictive Value: A CMR OxAMI Study
title_sort acute microvascular impairment post-reperfused stemi is reversible and has additional clinical predictive value: a cmr oxami study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718360/
https://www.ncbi.nlm.nih.gov/pubmed/30660541
http://dx.doi.org/10.1016/j.jcmg.2018.10.028
work_keys_str_mv AT borlottialessandra acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy
AT jeroschheroldmichael acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy
AT liudan acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy
AT vilianidafne acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy
AT braccoalessia acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy
AT alkhalilmohammad acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy
AT demariagiovanniluigi acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy
AT acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy
AT channonkeithm acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy
AT banningadrianp acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy
AT choudhuryrobinp acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy
AT neubauerstefan acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy
AT kharbandarajeshk acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy
AT dallarmellinaerica acutemicrovascularimpairmentpostreperfusedstemiisreversibleandhasadditionalclinicalpredictivevalueacmroxamistudy